Pancreatic Cancer Research

ResearcherHunan Normal UniversityNo recent work listed

Yan Liao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8584-7467; OpenAlex author ID A5016216463. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers

Papers 5

  1. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. Co-author DOI 10.1016/j.biocel.2022.106358↗
  2. Endoscopically guided interventional photodynamic therapy for orthotopic pancreatic ductal adenocarcinoma based on NIR-II fluorescent nanoparticles. Co-author DOI 10.7150/thno.84164↗
  3. ATX/LPA axis regulates FAK activation, cell proliferation, apoptosis, and motility in human pancreatic cancer cells. Co-author DOI 10.1007/s11626-022-00660-3↗
  4. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated… Co-author DOI 10.1007/s10620-014-3394-x↗
  5. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer. Co-author DOI 10.1007/s10620-013-2878-4↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Cheng · 2 shared papers, 2023 · strength 0.35
  2. Zhaohong Shi · 1 shared paper, 2022 · strength 0.22
  3. Manxiong Dai · 1 shared paper, 2023 · strength 0.19
  4. Kang Chen · 1 shared paper, 2023 · strength 0.19
  5. Hong‐Wen Liu · 1 shared paper, 2023 · strength 0.15
  6. Xu Chen · 1 shared paper, 2023 · strength 0.15
  7. Sulai Liu · 1 shared paper, 2023 · strength 0.15
  8. Ning Zhou · 1 shared paper, 2023 · strength 0.15
  9. Kang Chen · 1 shared paper, 2023 · strength 0.15
  10. Guosheng Song · 1 shared paper, 2023 · strength 0.15
  11. Ganggang Mu · 2 shared papers, 2013–2015 · strength 0.11
  12. Honggang Yu · 2 shared papers, 2013–2015 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.